"Computational Solutions for Life Sciences" presented by Accelrys
at the San Diego Supercomputer Center

DATE: Wednesdsay, June 1, 2005
TIME: 9:00 am – 1:00 pm
LOCATION: 1st Floor Auditorium, San Diego SuperComputer Center

AGENDA
9:15 am – 10:00 pm Proteomics Overview
Deepak Singh, Product Manager, Simulations & NMR,
Accelrys

10:00 pm – 12:00 pm Software Solutions from Accelrys/Product Demonstrations
Krishnamachari Raghavan, Lead Application Specialist,
Accelrys

12:00 pm – 1:00 pm LUNCH / Q&A

ABSTRACT
In Silico approaches are an integral part of Life Sciences research and development. The level of sophistication and accuracy of such methods are constantly increasing and these are routinely being used in the discovery
and development of novel chemicals and pharmaceuticals, as well as target characterization.

This presentation will provide an overview of Accelrys’ comprehensive product offerings for in silico research, in particular, will address solutions within InsightII, Discovery Studio Modeling and Catalyst suite of
products. The following topics will be covered during this presentation:

Ø Molecular Modeling/Simulations
Ø Structure-Based Design (Docking and de novo ligand design)
Ø Protein Modeling/Protein Engineering
Ø Pharmacophore models and 3D database mining

Registration is FREE, but to ensure we have enough refreshments, please send an email to lxm@accelrys.com or call Laurie Martensen at (858) 799-5554 to reserve a space.

Dr. Deepak Singh is currently the Product Manager, Simulations & NMR in the Computational Biology product marketing group at Accelrys. His role includes managing core modeling products such as CHARMm and Insight II, in addition to NMR products like FELIX and CNX-NMR. Prior to joining Accelrys,
Dr Singh was a staff scientist in the Scientific Algorithms Group at GeneFormatics, Inc (now Cengent Therapeutics) in San Diego, CA. Deepak obtained his Ph.D in Physical Chemistry from Syracuse University, where he used quantum mechanics and molecular dynamics simulations to study the photophysics and structural properties of retinal proteins.

Dr. Krishnamachari Raghavan is a Lead Application Specialist with Accelrys. Prior to joining Accelrys, Inc. (then Biosym Technologies) in 1994, Dr. Raghavan worked at the National Cancer Institute, NIH in Bethesda as NCI
General Fellow, where he focused on identifying and designing HIV integrase inhibitors and Topoisomerase inhibitors through computational methods. Dr. Raghavan has also worked as a Research Associate at Ames Laboratory, Ames Iowa and at the University of North Carolina, Chapel Hill, NC. He received his Ph.D. in Chemistry (Theoretical) from Indian Institute of Technology, Kanpur, India.